Feline Injection Site Sarcoma Treatment

Colleague, thank you for this consult. This presentation is highly concerning for a feline injection-site sarcoma (FISS), and your FNA findings support that. These tumors require an aggressive, well-planned, multimodal approach from the outset. A simple "lumpectomy" is inadequate and often leads to rapid, more invasive recurrence.

Here is the optimal plan:

1. Staging: Before any intervention, we need to know the extent of the disease.
* Local Staging: A contrast-enhanced CT scan is the gold standard and is non-negotiable for FISS. This is crucial for surgical planning, as these tumors often have microscopic tendrils that extend far beyond the palpable mass. I'll need Sarah to review the CT to define the tumor volume and its relationship to deep structures like the dorsal spinous processes.
* Metastatic Staging: Minimum database (CBC, chemistry, UA) and three-view thoracic radiographs are essential. The metastatic rate for FISS is approximately 20-25%, with the lungs being the most common site.

2. Surgical Margins & Approach: This is a case for radical excision.
* I'll defer to James for the surgical technique, but my recommendation based on oncology principles is 5 cm lateral margins and 2 fascial planes deep. This is the standard of care. Given the interscapular location, this will likely involve removing portions of the dorsal spinous processes and require advanced reconstructive techniques. The goal is a single, aggressive surgery to achieve clean margins.

3. Radiation Therapy:
* Multimodal therapy is superior to surgery alone. Pre-operative radiation is often preferred for FISS. It can help sterilize the tumor margins, potentially shrink the mass, and treats microscopic disease in a well-oxygenated field before surgical scarring occurs. Post-operative radiation is an alternative if margins are found to be incomplete on histopathology.

Prognosis:
This is entirely dependent on the approach.
* Surgery alone (with incomplete margins): Recurrence is nearly 100%, often within 2-4 months.
* Aggressive surgery (with clean margins): Median survival time (MST) is around 14-18 months, but local recurrence rates can still be high.
* Surgery + Radiation (the recommended multimodal approach): This offers the best prognosis, with an MST of 24-36 months and significantly improved local control.

In summary, the optimal plan is staging with CT and thoracic radiographs, followed by pre-operative radiation and then radical surgical excision. This isn't a simple mass removal; it's a significant oncologic battle that we have the best chance of winning with a coordinated, aggressive plan from day one.

Let me know once you have the imaging.

🧫
Dr. Rachel Torres, DVM, DACVIM (Oncology)

Colleagues, this is a classic presentation for a feline injection-site sarcoma (FISS), and it requires an aggressive, multimodal approach. The FNA is a good starting point, but our plan from here must be precise. The first surgery is the best and only real chance for a cure.

1. Staging is Mandatory Before Surgery:
Before I plan my incision, I need to know the local extent of the tumor and screen for metastasis.
* Local Staging: A contrast-enhanced CT of the primary mass is the gold standard. This is non-negotiable for FISS. It allows me to assess invasion into the underlying epaxial muscles, dorsal spinous processes, and scapulae, which is critical for planning the deep margins. I'll need Sarah Lin to read this and help me define the full extent of the disease.
* Metastatic Staging: 3-view thoracic radiographs are the minimum, but a thoracic CT (done at the same time as the local scan) is superior for detecting pulmonary nodules. The metastatic rate for FISS is reported at 10-25%.

2. Surgical Plan: Aggressive and Radical
This is not a "shell-out" procedure. My surgical goal is a single, en-bloc resection with wide, clean margins.
* Margins: The standard of care is 5 cm lateral margins and 2 fascial planes deep. For an interscapular mass, this often means resecting the dorsal aspects of the spinous processes and potentially part of the dorsal scapular cartilage. I will mark the 5cm margin circumferentially before my first incision.
* Biopsy: The entire resected tissue block, with margins clearly marked with suture tags or ink, must be submitted for histopathology to confirm the diagnosis, grade, and margin status.

3. Collaboration is Key:
I will perform the surgery, but the overall case management requires a team. I need to consult with Rachel Torres on the timing of radiation therapy. Pre-operative radiation can sometimes sterilize the tumor periphery, but it can also impact wound healing. Post-operative radiation is an option if we have narrow or incomplete margins, but it's a salvage procedure. Her input will determine our definitive sequence of therapy.

The prognosis is entirely dependent on achieving clean margins on this first attempt. With aggressive surgery alone, median survival times are around 2-3 years, but recurrence is common. Combining surgery with radiation offers the best chance at long-term local control. I'm ready to proceed once staging is complete and we have a consensus plan with oncology.

Colleagues,

From an imaging standpoint, proper staging is critical before any therapeutic intervention for a suspected FISS. This is not a "shell-out" procedure, and our imaging plan must reflect the aggressive nature of this tumor to guide both surgery and radiation therapy.

My recommendations are as follows:

Local Tumor Staging: A contrast-enhanced CT scan of the primary mass is the current standard of care. This is non-negotiable for accurate planning. Radiographs are insufficient. The CT will define the full extent of the tumor, including its invasiveness into underlying fascial planes, musculature (e.g., trapezius, rhomboideus), and spinous processes. This data is essential for Dr. Okafor to plan the aggressive surgical margins required. Post-contrast images will help delineate viable tumor from surrounding inflammation or edema, which is critical for Dr. Torres's radiation field planning.

Metastatic Staging: The most common site for distant metastasis is the lungs. A thoracic CT, performed concurrently with the primary tumor scan, is strongly recommended. CT is far more sensitive than three-view thoracic radiographs for detecting small pulmonary nodules, which can significantly alter prognosis and treatment recommendations. If CT is not an option for the client, three-view thoracic radiographs are the absolute minimum database.

Regional Lymph Node Evaluation: The CT will include evaluation of the regional lymph nodes (prescapular, axillary). Any nodes that are enlarged or show abnormal contrast enhancement should be considered for ultrasound-guided fine-needle aspiration.

In summary, the complete imaging workup should be a contrast-enhanced CT of the primary mass and thorax. This provides the essential roadmap for both the surgical and oncologic management of this case. I will defer to Dr. Okafor on the specifics of the surgical margins and to Dr. Torres on the radiation and chemotherapy protocols, as my role is to provide them with the most precise anatomical information possible.